Carey Kimmelstiel, MD
Cardiovascular Disease · Boston, MANPI 1043326713
Payments from drug & device makers
Across 1,002 payments — averaging $690.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$153K
- Edwards Lifesciences$144K
- GE HealthCare$138K
- Abbott$92K
- Johnson & Johnson$81K
- Shockwave Medical, Inc$30K
- plus $53K from 28 others
Across 6 payments — averaging $3045.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$18K
- Abiomed$272
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 197 | $152,694 |
| Edwards Lifesciences | 476 | $144,475 |
| GE HealthCare | 24 | $138,368 |
| Abbott | 95 | $91,835 |
| Johnson & Johnson | 76 | $81,158 |
| Shockwave Medical, Inc | 5 | $30,267 |
| Chiesi USA, Inc. | 25 | $26,915 |
| Procyrion, Inc. | 4 | $18,638 |
| Medtronic(2 entities) | 33 | $3,858 |
| Abiomed | 11 | $2,139 |
| Boehringer Ingelheim | 8 | $226 |
| Novartis | 8 | $188 |
| Pfizer | 6 | $176 |
| Acist Medical Systems, Inc. | 1 | $147 |
| Teleflex LLC | 2 | $136 |
| Cordis US CORP. | 1 | $123 |
| B. Braun Interventional Systems Inc. | 1 | $122 |
| Amgen | 5 | $117 |
| W. L. Gore & Associates, Inc. | 1 | $115 |
| Angiodynamics, Inc. | 2 | $114 |
| Biotronik Inc. | 1 | $81 |
| AstraZeneca | 4 | $75 |
| Acacia Pharma Inc | 2 | $42 |
| Vifor Pharma, Inc. | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Cardiva Medical, Inc. | 2 | $38 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Merck | 1 | $25 |
| Novo Nordisk | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Bayer | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Heartflow, Inc. | 1 | $13 |
How this compares
$692,273 in reported general payments places this provider in the 90th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Boston
- Marc SabatineBoston$31.2M
- Stephen WiviottBoston$29.2M
- David MorrowBoston$19M
- Scott SolomonBoston$16.2M
- Paul RidkerBoston$16.2M
- Mohit JainBoston$13M
- Calum MacraeBoston$11.4M
- Benjamin SciricaBoston$11.3M
- Robert GiuglianoBoston$10.5M
- Erin BohulaBoston$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.